BPC-157 and TB-500 are often mentioned in the same breath in peptide research. They are, however, different compounds with different backgrounds in the literature. This page sets the differences side by side โ purely informational, in a research context.
BPC-157, TB-500 and all other products at Peptide Europe are intended strictly for research purposes (research use only) and not for human or animal consumption. This page contains no usage or dosage information.
BPC-157
BPC-157 (Body Protection Compound) is a synthetic peptide derived from a sequence found in gastric juice. In the scientific literature it is described extensively in the context of tissue and cell research. As a research compound it is supplied as a freeze-dried powder.
TB-500
TB-500 is a synthetic fragment related to thymosin beta-4, a naturally occurring protein. TB-500 is also a widely studied compound in research on cell migration and tissue. It is likewise supplied as a freeze-dried powder.
Key differences at a glance
- Origin: BPC-157 is derived from a gastric juice sequence; TB-500 is related to thymosin beta-4.
- Structure: they are different peptides with different amino acid sequences.
- Research context: both appear in tissue research, but in different lines of the literature.
Often studied together
Because they frequently appear together in research, Peptide Europe also offers them as a standardised blend. Both compounds and the blend are HPLC-tested and independently verified.
View BPC-157 or the BPC-157 + TB-500 blend โ intended strictly for research purposes.